Cost evaluation of branded and generic drugs
Szuba, T.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy 19(2): 137-142
1987
ISSN/ISBN: 0025-5246 PMID: 3448420 Document Number: 293461
Document emailed within 1 workday
Related Documents
Worth, T. 2015: The rising cost of generic drugs Medical Economics 92(5): 36-39Ansa Erice, I.; Agudo Pascual, C.; Artazcoz Sanz, M.; Carnicero Giménez de Azcárate, J. 1996: Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra Atencion Primaria 17(6): 411-414
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Bangalee, V; Suleman, F 2016: Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Health Sa Gesondheid 21: 60-66
Fioranelli, M.; Hercogovấ, J.; Gianfaldoni, S.; Chokoeva, A.A.; Tchernev, G.; Wollina, U.; Tirant, M.; Novotny, F.; Roccia, M.G.; Maximov, G.K.; França, K.; Lotti, T. 2016: Clinical evaluation of the effectiveness of Dr Michaels® (also branded as Soratinex®) products in the topical treatment of patients with plaque psoriasis Journal of Biological Regulators and Homeostatic Agents 30(2 Suppl 3: 29-34
Zapater, P.; Horga, J.F. 2000: Bio-equivalence and generic drugs. Studies of bio-equivalence. II. Special situations. Reflections on problems which may arise with drugs habitually used in neurology Revista de Neurologia 30(2): 146-154
Katz, A.; Zalzstein, E. 2001: Generic antiarrhythmics: safety and efficacy versus cost Harefuah 140(11): 1087-1090
Ayd, F.J. 1978: Generic drugs Journal of Clinical Psychiatry 39(10): 789
García-Arieta, A.; Blázquez-Pérez, A.; de la Barrera, P.P.; Pozo-Hernández, C.; Vargas-Castrillón, E. 2006: Regarding generic antiepileptic drugs Revista de Neurologia 43(7): 446-8; Author Reply 448
Mack, R.B. 1988: Concern about generic drugs North Carolina Medical Journal 49(12): 665
2002: Generic drugs. Understanding their value Mayo Clinic Health Letter 20(1): 7
Tremblay, J. 1980: Prescription drugs and the aged: cost-free and cost-containment measures L'Union Medicale du Canada 109(3): 414-420
Robbins, N.; Barzel, U.S. 1988: Generic drugs--a question of safety New York State Journal of Medicine 88(8): 441-442
Taylor, J.M. 1978: Color scheme for generic drugs New England Journal of Medicine 298(20): 1152
Reiffel, J.A. 2001: Issues in the use of generic antiarrhythmic drugs Current Opinion in Cardiology 16(1): 23-29
Marx, G.F. 1990: Trade and generic names of drugs New York State Journal of Medicine 90(10): 517
Gogtay, J.A. 2007: The impact of generic antiviral drugs Idrugs: the Investigational Drugs Journal 10(12): 881-884
Levy, R. 1999: Utilization of interchangeable generic drugs in Mexico Salud Publica de Mexico 41(5): 435
Chalchat, B. 1996: Generic drugs and substitution rights: Pandora's box? Annales Pharmaceutiques Francaises 54(6): 284-286